For: | Wang S, Yong H, He XD. Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus. World J Diabetes 2021; 12(7): 1070-1080 [PMID: 34326955 DOI: 10.4239/wjd.v12.i7.1070] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i7/1070.htm |
Number | Citing Articles |
1 |
Mohammed Alfaifi. Interaction between rs6446482 polymorphisms in the WFS1 gene in type 2 diabetes patients. Journal of King Saud University - Science 2022; 34(1): 101721 doi: 10.1016/j.jksus.2021.101721
|
2 |
Xue Tian, Yu Gao, Min Zhong, Mowei Kong, Lihua Zhao, Zengbin Feng, Qitian Sun, Jianqiu He, Xiaoyan Liu. The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus. BMC Cardiovascular Disorders 2022; 22(1) doi: 10.1186/s12872-022-02727-1
|
3 |
Prashant Kumar, Swarna Kanchan, Minu Kesheri. Microbial Omics in Environment and Health. 2024; : 205 doi: 10.1007/978-981-97-1769-9_8
|
4 |
Setegn Eshetie, Karmel W. Choi, Elina Hyppönen, Beben Benyamin, S. Hong Lee. Integrative multi-omics analysis to gain new insights into COVID-19. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79904-z
|
5 |
M. I. Farrim, A. Gomes, D. Milenkovic, R. Menezes. Gene expression analysis reveals diabetes-related gene signatures. Human Genomics 2024; 18(1) doi: 10.1186/s40246-024-00582-z
|
6 |
Vladimir V. Chrishtop, Artur Y. Prilepskii, Varvara G. Nikonorova, Vladimir A. Mironov. Nanosafety vs. nanotoxicology: adequate animal models for testing in vivo toxicity of nanoparticles. Toxicology 2021; 462: 152952 doi: 10.1016/j.tox.2021.152952
|
7 |
Jinghan Xu, Chunli Piao, Yue Qu, Tianjiao Liu, Yuting Peng, Qi Li, Xiaohua Zhao, Pei Li, Xuemin Wu, Yawen Fan, Binqin Chen, Jie Yang. Efficacy and mechanism of Jiedu Tongluo Tiaogan Formula in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease: Study protocol for a parallel-armed, randomized controlled trial. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.924021
|
8 |
Naser Alsharairi. A Review of Experimental Studies on Natural Chalcone-Based Therapeutic Targeting of Genes and Signaling Pathways in Type 2 Diabetes Complications. Genes 2024; 15(7): 942 doi: 10.3390/genes15070942
|
9 |
Enmin Ding, Fuchang Deng, Jianlong Fang, Tiantian Li, Minmin Hou, Juan Liu, Ke Miao, Wenyan Yan, Ke Fang, Wanying Shi, Yuanzheng Fu, Yuanyuan Liu, Haoran Dong, Li Dong, Changming Ding, Xiaohui Liu, Krystal J. Godri Pollitt, John S. Ji, Yali Shi, Yaqi Cai, Song Tang, Xiaoming Shi. Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60–69 Years of Age: Evidence from the China BAPE Study. Environmental Health Perspectives 2023; 131(4) doi: 10.1289/EHP11896
|
10 |
Omar Ramos-Lopez. Genotype-based precision nutrition strategies for the prediction and clinical management of type 2 diabetes mellitus. World Journal of Diabetes 2024; 15(2): 142-153 doi: 10.4239/wjd.v15.i2.142
Abstract(367) |
Core Tip(349) |
Full Article(HTML)(2329)
|
Full Article with Cover (PDF)-795K(77)
|
Full Article (Word)-141K(20)
|
Audio-563K(4)
|
Peer-Review Report-221K(46)
|
Answering Reviewers-165K(50)
|
Full Article (PDF)-458K(158)
|
Full Article (XML)-222K(46)
|
Times Cited (0)
|
Total Visits (4411)
|
Open
|
11 |
Javier Suárez, Federico Boem. Technology-driven surrogates and the perils of epistemic misalignment: an analysis in contemporary microbiome science. Synthese 2022; 200(6) doi: 10.1007/s11229-022-03912-7
|
12 |
Xin Zhang, Erwin Kupczyk, Philippe Schmitt-Kopplin, Constanze Mueller. Current and future approaches for in vitro hit discovery in diabetes mellitus. Drug Discovery Today 2022; 27(10): 103331 doi: 10.1016/j.drudis.2022.07.016
|
13 |
Md. Numan Islam, Md. Golam Rabby, Md. Munnaf Hossen, Md. Mostafa Kamal, Md. Ashrafuzzaman Zahid, Md. Syduzzaman, Md. Mahmudul Hasan, Bertrand Blondeau. In silico functional and pathway analysis of risk genes and SNPs for type 2 diabetes in Asian population. PLOS ONE 2022; 17(8): e0268826 doi: 10.1371/journal.pone.0268826
|
14 |
Varsha K. Singh, Sapana Jha, Palak Rana, Amit Gupta, Ashish P. Singh, Neha Kumari, Rajeshwar P. Sinha. Microbial Omics in Environment and Health. 2024; : 57 doi: 10.1007/978-981-97-1769-9_3
|
15 |
Golnoosh Mahjoob, Yasin Ahmadi, Huda Fatima rajani, Nafiseh khanbabaei, Sakhavat Abolhasani. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients. Journal of Clinical Laboratory Analysis 2022; 36(5) doi: 10.1002/jcla.24380
|
16 |
Ousman Bajinka, Yurong Tan, Alansana Darboe, Isabella Gloria Ighaede-Edwards, Khalid A. Abdelhalim. The gut microbiota pathway mechanisms of diabetes. AMB Express 2023; 13(1) doi: 10.1186/s13568-023-01520-3
|
17 |
Duygu Ağagündüz, Mehmet Arif Icer, Ozge Yesildemir, Tevfik Koçak, Emine Kocyigit, Raffaele Capasso. The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04088-5
|
18 |
Yan Wang, Bohan Lv, Nannan Liu, Siyu Tao, Jinfang Dou, Jun Li, Ruxue Deng, Xiuyan Yang, Guangjian Jiang. The mechanism of bile acid metabolism regulating lipid metabolism and inflammatory response in T2DM through the gut-liver axis. Heliyon 2024; 10(16): e35421 doi: 10.1016/j.heliyon.2024.e35421
|
19 |
Fei Yuan, Yu‐Hang Zhang, FeiMing Huang, Xiaoyu Cao, Lei Chen, JiaBo Li, WenFeng Shen, KaiYan Feng, YuSheng Bao, Tao Huang, Yu‐Dong Cai. Prediction of Lung Adenocarcinoma Driver Genes Through Protein–Protein Interaction Networks Utilizing GenePlexus. PROTEOMICS 2024; doi: 10.1002/pmic.202400296
|